New collagen mesh could reduce hernia surgery risks

NCT ID NCT07360691

Completed Disease control Sponsor: Adichunchanagiri Institute of Medical Sciences, B G Nagara Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a special collagen mesh for hernia repair in 30 patients who were at high risk for complications, such as those with diabetes or infections. The mesh is designed to be absorbed by the body and help tissue heal naturally, avoiding problems linked to permanent synthetic mesh. Researchers tracked safety and wound healing for 8 weeks after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: High-Purity Type I Collagen Mesh (Surgicoll-Mesh®)
What this could lead to: If successful, this collagen mesh could offer a safer option for hernia repair in patients at high risk of complications, reducing infection and other issues.
What could go wrong: This is a small, early study with only 30 participants and no comparison group. The mesh is resorbable and may not provide long-term strength, and results may not apply to all hernia types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL WALL HERNIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hernia Hernia, Abdominal Hernia, Inguinal Hernia, Ventral hiatus hernia Incisional Hernia Osteogenesis Imperfecta, Type IV Pain, Postoperative Postoperative Complications Surgical Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ABDOMINAL WALL HERNIA HERNIA INCISIONAL HERNIA İNGUINAL HERNIA POSTOPERATIVE COMPLICATIONS SURGICAL SITE INFECTION VENTRAL HERNIA

Contacts and locations

Locations

Adichunchanagiri Institute of Medical Sciences

Mandya, Karnataka, 571448, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.